Although a slight trend towards increased tumor take of sarcomas transplanted from NCF1*/* mutant mice was observed, this difference was not significant and did not support a role for NOX2 produced ROS in immune editing of MCA induced sarcomas. The gene discussed is NCF1; the disease is sarcoma.